Nanoform is a pioneering brand that emerged in 2015 from the groundbreaking collaboration between Prof. Jouko Yliruusi and Prof. Edward Hæggström, experts in pharmaceutical technology and physics respectively.

Their combined brilliance led to the creation of a revolutionary particle engineering technology known as Controlled Expansion of Supercritical Solutions (CESS®). Guided by a passion for innovation, Nanoform aims to unlock the full potential of pharmaceuticals through their cutting-edge nanoforming services. This Finnish success story with a global vision provides a wide range of technologies and services that cater to the entire drug development process, from small-molecule to large-molecule therapeutics.

Their aim is to assist the global pharmaceutical industry in doubling its annual new medicines output, propelling it into a new era of discovery and advancement. With their dedication to excellence and commitment to innovation, Nanoform is making waves in the industry and shaping the future of medicine. Explore the possibilities and join the journey of transforming the pharmaceutical industry with Nanoform